CIK 0001681682
- Non-accelerated filer
- Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260579295
- Phone
- +1 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Technology Officer bought 15,000 shares at $1.65 ($24,750)
- 4 Open-market buy Director bought 83,333 shares at $1.20 ($100,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Technology Officer bought 1,500 shares at $3.40 ($5,100)
- 4 Open-market buy Director bought 10,000 shares at $0.17 ($1,700)
- 4 Open-market buy Chief Technology Officer bought 20,000 shares at $0.27 ($5,400)
- 4 Open-market buy Director bought 20,000 shares at $0.26 ($5,200)
- 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.21 ($5,250)
- 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.22 ($5,500)
- 4 Open-market buy Chief Executive Officer bought 5,100 shares at $0.19 ($969)
- 4 Open-market buy Director bought 100,000 shares at $0.20 ($19,630)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 174 filings